The study for the relation of FXIII activity with intraoperative bleeding and morbidity in hepatobiliary surgery.

The study for the relation of FXIII activity with intraoperative bleeding and morbidity in hepatobiliary surgery. - The study for the relation of FXIII activity with intraoperative bleeding.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014580

Enrollment

Registered

2014-08-01

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are going to undergo hepatic lobectomy or pancreaticoduodenectomy (irrespective of disease type)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients age at 20 or more 2) patients who undergo hepatic lobectomy or pancreaticoduodenectomy (irrespective of disease). 3) patients who agreed to participate this study

Exclusion criteria

Exclusion criteria: 1) patients who refused to participate this study 2) patients who are not eligible to participate this study (by the decision of responsible physician)

Design outcomes

Primary

Measure	Time frame
The association between the activity of factor XIII and intraoperative bleeding, intra/postoperative blood transfusion.	—

Secondary

Measure	Time frame
The association between the activity of factor XIII and postoperative liver failure, bile leakage, pancreatic fistula, anastomotic failure, and infectious complications.	—

Countries

Japan

Contacts

Public ContactYukihiro Yokoyama

Nagoya University Hospital Surgery 1

yyoko@med.nagoya-u.ac.jp052-744-2222

Outcome results